AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19083441
Drug: Antioxidant vitamins
RxNorm normalized name: antioxidant vitamins with minerals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant vitamins (vitamin C 1000 mg and vitamin E 800 IU)
Trial: 8061849
Drug: Spirapril treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril treatment (initial dose 6 or 12 mg once daily, titrated to 3-24 mg)
Trial: 8061849
Drug: Spirapril treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril treatment
Trial: 4904222
Drug: Hyperosmolar and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperosmolar and hypoosmolar solutions
Trial: 11099758
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of dexamphetamine sulphate
Trial: 11099758
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of dexamphetamine sulphate
Trial: 7921303
Drug: Daily vitamin
RxNorm normalized name: Daily Vitamin Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily vitamin and mineral supplements for 6 years
Trial: 7921303
Drug: Daily supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplementation of four different vitamin and mineral combinations for 5 1/4 years
Trial: 24256453
Drug: Group music
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group music therapy (GMT)
Trial: 29798206
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with 10mg oral ebastine plus 200 μg intranasal mometasone furoate once daily (combined group)
Trial: 29798206
Drug: Double-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose oral ebastine 20 mg once daily (double-dose group)
Trial: 22561772
Drug: Muscle Relaxant
RxNorm normalized name: MUSCLE RELAXANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscle Relaxant + anti‐depressant drug (n=26)
Trial: 22561772
Drug: Physiotherapy +
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiotherapy + antidepressant drug + muscle relaxant (n=6)
Trial: 19667999
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of metformin 1700 mg/day and rosiglitazone 4 mg/day
Trial: 15136950
Drug: Metformin 1700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1700 mg/day
Trial: 18721168
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous insulin infusion (CSII), n = 34
Trial: 18721168
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily injections (MDI), n = 38
Trial: 17135985
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fluoxetine (FLX) and cognitive-behavioral therapy (CBT)
Trial: 17135985
Drug: Clinical management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical management with pill placebo (PBO)
Trial: 14575277
Drug: manidipine 20
RxNorm normalized name: manidipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: manidipine 20 mg daily
Trial: 14575277
Drug: nifedipine 60
RxNorm normalized name: nifedipine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nifedipine 60 mg daily
Trial: 1383574
Drug: finasteride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: finasteride (10 mg per day)
Trial: 3996091
Drug: Tinidazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (500 mg intravenous infusion)
Trial: 2888606
Drug: Oral tinidazole
RxNorm normalized name: Tinidazole
DrugBank: Tinidazole (DB00911)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tinidazole
Trial: 31291515
Drug: Galcanezumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galcanezumab (300 mg, subcutaneously at baseline and at 1 month)
Trial: 31291515
Drug: Galcanezumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galcanezumab (300 mg)
Trial: 24853120
Drug: Curcuminoids (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuminoids (1500 mg/day in 3 divided doses)
Trial: 12053718
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose therapy
Trial: 27093747
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (15 g)
Trial: 7607713
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg losartan + 25 mg hydrochlorothiazide
Trial: 7607713
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg losartan + 25 mg hydrochlorothiazide
Trial: 7607713
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg losartan + 25 mg hydrochlorothiazide
Trial: 7607713
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + 25 mg hydrochlorothiazide
Trial: 2218421
Drug: Ofloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 400 mg once daily for 10-14 days
Trial: 2218421
Drug: Doxycycline 200
RxNorm normalized name: doxycycline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 200 mg once daily followed by 100 mg once daily for 10-14 days
Trial: 28455250
Drug: Video and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video and oral sucrose solution (sucrose)
Trial: 28455250
Drug: Video and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video and sucrose and topical liposomal lidocaine (lidocaine)
Trial: 26266386
Drug: Sufentanil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil plus dexmedetomidine (0.02 μg/kg/h sufentanil + 0.05 μg/kg/h dexmedetomidine) (Group D2)
Trial: 26266386
Drug: Sufentanil (0.02 μg/kg/h)
DrugBank: Sufentanil (DB00708)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sufentanil (0.02 μg/kg/h) (Group C)
Trial: 26266386
Drug: Sufentanil plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil plus dexmedetomidine (0.02 μg/kg/h sufentanil + 0.02 μg/kg/h dexmedetomidine) (Group D1)
Trial: 24057042
Drug: Lapatinib (1,250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib (1,250 mg once daily) and Everolimus (5 mg once daily)
Trial: 24057042
Drug: Lapatinib and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib and Everolimus combination
Trial: 12716684
Drug: 4.5 g
RxNorm normalized name: Zosyn 4.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 g ALA/d
Trial: 12663273
Drug: 9.5 g
RxNorm normalized name: Pedia-Lax Saline, 9.5 g-3.5 g/66 mL rectal enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9.5 g ALA/d
Trial: 12716684
Drug: 0.77 g
RxNorm normalized name: ISOPROPYL ALCOHOL 0.77 g in 1 mL TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.77 g EPA+DHA/d
Trial: 12663273
Drug: 1.7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.7 g EPA+DHA/d
Trial: 1345038
Drug: Pyruvate (36-53
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyruvate (36-53 g)
Trial: 1345038
Drug: Placebo (Polycose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (Polycose, 21-37 g)
Trial: 21681921
Drug: IL-2 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-2 therapy infused on days 0-3 and 8-17
Trial: 21681921
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further therapy (AML control group)
Trial: 11294480
Drug: Brofaromine (reversible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brofaromine (reversible monoamine oxidase A inhibitor)
Trial: 9398716
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg, three times daily for 4-6 weeks)
Trial: 7049817
Drug: Atenolol, 100
RxNorm normalized name: Atenolol, 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol, 100 mg once daily
Trial: 24684734
Drug: Transdermal clonidine
RxNorm normalized name: clonidine Transdermal System
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal clonidine (5 mg patch)
Trial: 23557068
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg udenafil + tamsulosin placebo
Trial: 23557068
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg udenafil + 0.4 mg tamsulosin
Trial: 23557068
Drug: udenafil placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: udenafil placebo + 0.4 mg tamsulosin
Trial: 21434580
Drug: Memantine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (20 mg) with buprenorphine placebo
Trial: 21434580
Drug: Buprenorphine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (2 mg) with memantine placebo
Trial: 19887810
Drug: Quality of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quality of life, coping, global assessments of treatment success
Trial: 10770146
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens, 0.625 mg, plus medroxyprogesterone acetate, 2.5 mg, in 1 tablet daily (n = 1380)
Trial: 3591595
Drug: Terodiline hydrochloride
RxNorm normalized name: Terodiline hydrochloride
DrugBank: Terodiline (DB13725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terodiline hydrochloride 24 mg once a day for 4 weeks
Trial: 3591595
Drug: Terodiline hydrochloride
RxNorm normalized name: Terodiline hydrochloride
DrugBank: Terodiline (DB13725)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terodiline hydrochloride 12 mg once a day for 4 weeks
Trial: 27016217
Drug: Flotation-REST treatment
RxNorm normalized name: Rest Simply
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flotation-REST treatment (12 sessions)
Trial: 24608453
Drug: Sulfasalazine with
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfasalazine with temozolomide and radiation therapy
Trial: 24608453
Drug: Temozolomide and
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide and radiation therapy (Control)
Trial: 23478632
Drug: Daily Disposable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Disposable (DD) contact lenses
Trial: 23478632
Drug: Daily Wear
RxNorm normalized name: ZINC OXIDE 22.7 g in 100 g TOPICAL LOTION [ETHICAL ZINC DAILY WEAR LIGHT SUNSCREEN SPF-50]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Wear with Hydrogen Peroxide (DW-H2O2)
Trial: 23478632
Drug: Daily Wear
RxNorm normalized name: ZINC OXIDE 22.7 g in 100 g TOPICAL LOTION [ETHICAL ZINC DAILY WEAR LIGHT SUNSCREEN SPF-50]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Wear with Multipurpose Solutions (DW-MPS)
Trial: 16020461
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of food intake and exercise
Trial: 12559641
Drug: Combined lung
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined lung cancer prevention agent (specifics not provided)
Trial: 9858113
Drug: Cortisol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol (200 mg/day)
Trial: 7596966
Drug: State Modulation
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: State Modulation (SM) treatment
Trial: 2187001
Drug: Theophylline treatment
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theophylline treatment (two different dosage regimens)
Trial: 9037573
Drug: Domperidone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (30 mg/day)
Trial: 382149
Drug: Domperidone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (30 mg/day) during open phase
Trial: 27475087
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of dasatinib once daily
Trial: 27475087
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg of dasatinib twice daily
Trial: 25129979
Drug: Intramuscular NGF
RxNorm normalized name: Panthenol 1 g in 100 mL TOPICAL SOLUTION [NGF 574H HAIR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular NGF treatment
Trial: 25129979
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (intravenous vasodilators, energy mixture, steroid pulse therapy, methylcobalamin neurotrophic therapy)
Trial: 18949181
Drug: Saccharomyces boulardii
RxNorm normalized name: Saccharomyces boulardii
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saccharomyces boulardii (500 mg/day) for 12 days
Trial: 15843667
Drug: Gatifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin (400 mg daily for 2 weeks, then 10-day course every month for 2 years)
Trial: 10351964
Drug: Abciximab (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abciximab (bolus 0.25 mg/kg and 12-hour infusion of 0.125 microg/kg/min)
Trial: 10351964
Drug: Accelerated-dose alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Accelerated-dose alteplase (100 mg)
Trial: 10351964
Drug: Alteplase (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alteplase (50 mg, 15 mg bolus; infusion of 35 mg over 60 minutes) plus abciximab
Trial: 10351964
Drug: Alteplase (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alteplase (50 mg, 15 mg bolus; infusion of 35 mg over 60 minutes) plus abciximab and low-dose heparin
Trial: 10351964
Drug: Alteplase (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alteplase (50 mg, 15 mg bolus; infusion of 35 mg over 60 minutes) plus abciximab and very-low-dose heparin
Trial: 8824651
Drug: Psyllium (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (5 g b.d.)
Trial: 2117517
Drug: Levonorgestrel (L‐Ng,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel (L‐Ng, 0.03 mg twice a day for 20 days)
Trial: 2117517
Drug: Ethinylestradiol (EE,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethinylestradiol (EE, 0.05 mg per day for 20 days)
Trial: 2117517
Drug: Ibuprofen (Ib,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (Ib, 800 mg three times a day for 5 days)
Trial: 2117517
Drug: Placebo (PL,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PL, one pill of lactose for 20 days)
Trial: 7352687
Drug: Epinephrine 0.1
RxNorm normalized name: epinephrine 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine 0.1 mg
Trial: 7352687
Drug: Epinephrine 0.1
RxNorm normalized name: epinephrine 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine 0.1 mg (repeated administration)
Trial: 30939422
Drug: Sugammadex (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (Group S, n = 40) - 2 mg/kg
Trial: 30939422
Drug: Neostigmine (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (Group N, n = 44) - 1 mg neostigmine methylsulfate and 0.2 mg glycopyrrolate
Trial: 26091743
Drug: Evidence-based training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based training on providing counselling and insertion of IUDs or progestin implants
Trial: 20137622
Drug: Transurethral electro-resection
RxNorm normalized name: ELECTRODE SPRAY,ELECTRO MIST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transurethral electro-resection or electric coagulation combined with bladder instillation of anti-tumor drugs (control group)
Trial: 15339759
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for stress urinary incontinence
Trial: 15056514
Drug: Risperidone (0.02-0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (0.02-0.06 mg/kg/day, mean dose 1.5 mg/day)
Trial: 11822756
Drug: Topotecan and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan and Etoposide (dose level 3: T/E 1.00/100 mg/m2 and 75 mg/m2 respectively)
Trial: 1177348
Drug: Co-trimoxazole (trimethoprim/sulphamethoxazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (trimethoprim/sulphamethoxazole, 10 mg trimethoprim/kg/day in two divided daily doses for 10 days)
Trial: 1177348
Drug: Chloramphenicol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol (100 mg/kg/day in four divided daily doses for 10 days)
Trial: 25372657
Drug: Problem adaptation
RxNorm normalized name: Psoriasin Problem Skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem adaptation therapy (PATH)
Trial: 25372657
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy for cognitively impaired patients (ST‐CI)
Trial: 27654854
Drug: Tolvaptan (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (30 mg)
Trial: 1456569
Drug: Furosemide (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (80 mg)
Trial: 1727581
Drug: Intrauterine PGF2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine PGF2 alpha infusion (20 mg diluted in 500 mL NaCl 0.9%)
Trial: 1727581
Drug: IV oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV oxytocin infusion (increasing doses)
Trial: 26890999
Drug: Adolescent Coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adolescent Coping With Depression Course and Functional Family Therapy for SUD (depression treatment followed by SUD treatment)
Trial: 26890999
Drug: Adolescent Coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adolescent Coping With Depression Course and Functional Family Therapy for SUD (SUD treatment followed by depression treatment)
Trial: 26890999
Drug: Adolescent Coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adolescent Coping With Depression Course and Functional Family Therapy for SUD (coordinated treatment)
Trial: 20404423
Drug: Allopurinol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (100 mg/d)
Trial: 17692615
Drug: Fenoldopam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam (0.1 mg*kg‐1*min‐1)
Trial: 17692615
Drug: Dopamine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine (3 mg*kg‐1*min‐1)
Trial: 9785761
Drug: Exercise group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise group (15 women) - daily outdoor walking and gymnastic training for 12 months
Trial: 2744910
Drug: Carbocysteine (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbocysteine (4.5 g/day)
Trial: 6113175
Drug: Lormetazepam (Noctamid)
RxNorm normalized name: lormetazepam Oral Tablet [Noctamid]
DrugBank: Lormetazepam (DB13872)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lormetazepam (Noctamid) 1 mg
Trial: 6113175
Drug: Diazepam (Valium)
RxNorm normalized name: diazepam Oral Tablet [Valium]
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazepam (Valium) 5 mg
Trial: 29765200
Drug: AZD1981 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1981 (400 mg BID)
Trial: 29765200
Drug: AZD1981 (other
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1981 (other doses)
Trial: 27391857
Drug: Gynura pseudochina
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gynura pseudochina DC. var. hispida Thv. ointment
Trial: 27391857
Drug: 0.1% triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% triamcinolone (TA) cream
Trial: 21257799
Drug: Roflumilast (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roflumilast (oral daily doses for 14 days)
Trial: 21257799
Drug: Digoxin (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (single oral dose on day 1)
Trial: 19171611
Drug: School-based supervised
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based supervised therapy
Trial: 9613305
Drug: Low-dose regional
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose regional labour analgesia (bupivacaine and fentanyl)
Trial: 7859894
Drug: Easiest mode
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Easiest mode of insulin injection
Trial: 7859894
Drug: Two different
RxNorm normalized name: IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINEPROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY, BIPARATOPIC (TARGETING TWO DIFFERENT NON-OVERLAPP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two different forms of insulin delivery
Trial: 31337414
Drug: Two-way texting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-way texting intervention (daily text messages with follow-up only if desired or if a complication is suspected)
Trial: 24423419
Drug: Fospropofol (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fospropofol (initial dose of 6.5 mg/kg, supplemental doses of 1.6 mg/kg as needed)